Synovitis
Not recruitingStudy on the Safety and Effects of AMB-05X Injections for Patients with Tenosynovial Giant Cell Tumor
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Amb-05X
- Sponsor:Ammax Bio Inc.
Rare diseases
Investigational molecules
Locations
555 Twin Dolphin Drive Suite 610, 94065-2130, United States
Ammax Bio Inc. is focused on clinical research in tenosynovial giant cell tumor, a rare proliferative disorder affecting the synovial lining of joints and tendon sheaths. Its current trial activity centers on treatment approaches for symptomatic joint disease and local tumor control.
The sponsor’s research interest in this area reflects a therapeutic emphasis on conditions where intra-articular intervention is relevant to disease management and preservation of joint function.
Ammax Bio Inc. runs clinical trials in conditions such as Synovitis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
The NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.